Women with Alzheimer's disease (AD) have higher prevalence and more severe dementia syndrome than men with AD, and the brain regions are also affected differently. However, the underlying mechanisms are poorly understood.
Objective
To characterize the sex-dependent and region-specific gene expression in AD brain.
Methods
A previously published large scale bulk tissue gene expression dataset from postmortem brain samples across 19 cortical regions of normal control and individuals diagnosed with dementia and neuropathology of AD was used for differential gene expression analysis. Functional enrichment analysis was used to identify enriched biological functions or pathways related to selected genes. Protein expression level of a selected gene was validated by western blot.
Results
We identified 113 dysregulated genes in 11 AD brain regions (9 in men, 7 in women, and 5 shared between men and women). Notably, more dysregulated genes were found in women AD brain (77 genes) than in men (49 genes), and 13 dysregulated genes across these 11 brain regions were shared between women and men. Functional analysis further revealed the distinctive enrichment in categories of cellular component, biological process, and/or molecular function in these dysregulated genes. GPR34 gene expression was upregulated in the men AD brain across three different regions and a significant elevation of GPR34 protein level was confirmed in men AD brain.
Conclusions
These findings provide insight into sex- and brain region-specific gene expression dysregulation, which may indicate novel mechanisms underlying AD pathogenesis and will facilitate the development of personalized diagnosis and treatment strategies for AD.
MatthewsKAXuWGagliotiAH, et al.Racial and ethnic estimates of Alzheimer's disease and related dementias in the United States (2015-2060) in adults aged >/=65 years. Alzheimers Dement2019; 15: 17–24.
3.
FernandezACuestaPMarcosA, et al.Sex differences in the progression to Alzheimer's disease: a combination of functional and structural markers. Geroscience2024; 46: 2619–2640.
4.
ZhuDMontagneAZhaoZ. Alzheimer's pathogenic mechanisms and underlying sex difference. Cell Mol Life Sci2021; 78: 4907–4920.
5.
DumitrescuLMayedaERSharmanK, et al.Sex differences in the genetic architecture of Alzheimer's disease. Curr Genet Med Rep2019; 7: 13–21.
6.
FisherDWBennettDADongH. Sexual dimorphism in predisposition to Alzheimer's disease. Neurobiol Aging2018; 70: 308–324.
7.
ZhouXCaoJZhuL, et al.Molecular differences in brain regional vulnerability to aging between males and females. Front Aging Neurosci2023; 15: 1153251.
8.
DjordjevicJThomsonEChowdhurySR, et al.Brain region- and sex-specific alterations in mitochondrial function and NF-kappaB signaling in the TgCRND8 mouse model of Alzheimer's disease. Neuroscience2017; 361: 81–92.
9.
KimSHanSChoSA, et al.Brain region-dependent alternative splicing of Alzheimer disease (AD)-risk genes is associated with neuropathological features in AD. Int Neurourol J2022; 26: S126–S136.
10.
KayaIJennischeELangeS, et al.Brain region-specific amyloid plaque-associated myelin lipid loss, APOE deposition and disruption of the myelin sheath in familial Alzheimer's disease mice. J Neurochem2020; 154: 84–98.
11.
RenGSongSZhangSX, et al.Brain region-specific genome-wide deoxyribonucleic acid methylation analysis in patients with Alzheimer's disease. Front Mol Neurosci2023; 16: 971565.
12.
DeyMGunn-MooreFJPlattB, et al.Brain region-specific lipid alterations in the PLB4 hBACE1 knock-in mouse model of Alzheimer's disease. Lipids Health Dis2020; 19: 201.
13.
PatilSBaluDMelroseJ, et al.Brain region-specificity of palmitic acid-induced abnormalities associated with Alzheimer's disease. BMC Res Notes2008; 1: 20.
14.
WangMRoussosPMcKenzieA, et al.Integrative network analysis of nineteen brain regions identifies molecular signatures and networks underlying selective regional vulnerability to Alzheimer's disease. Genome Med2016; 8: 104.
15.
ShermanBTHaoMQiuJ, et al.DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res2022; 50: W216–W221.
16.
NavarroJFCroteauDLJurekA, et al.Spatial transcriptomics reveals genes associated with dysregulated mitochondrial functions and stress signaling in Alzheimer disease. iScience2020; 23: 101556.
17.
TangXTenaJDi LucenteJ, et al.Transcriptomic and glycomic analyses highlight pathway-specific glycosylation alterations unique to Alzheimer's disease. Sci Rep2023; 13: 7816.
18.
WangXLLiL. Cell type-specific potential pathogenic genes and functional pathways in Alzheimer's disease. BMC Neurol2021; 21: 381.
19.
LinLLSongGJZhangH, et al.GPR34 Knockdown relieves cognitive deficits and suppresses neuroinflammation in Alzheimer's disease via the ERK/NF-kappaB signal. Neuroscience2023; 528: 129–139.
20.
ManevHManevR. 5-Lipoxygenase (ALOX5) and FLAP (ALOX5AP) gene polymorphisms as factors in vascular pathology and Alzheimer's disease. Med Hypotheses2006; 66: 501–503.
21.
SiddiquiAAkhtarSShahZ, et al.Inflammation drives Alzheimer's disease: emphasis on 5-lipoxygenase pathways. Curr Neuropharmacol2021; 19: 885–895.
22.
HosseinianSArefianERakhsh-KhorshidH, et al.A meta-analysis of gene expression data highlights synaptic dysfunction in the hippocampus of brains with Alzheimer's disease. Sci Rep2020; 10: 8384.
23.
ShyTWGauravA. Pharmacophore modelling and virtual screening studies for the discovery of potential natural products based PDE1B inhibitor lead compounds. Cent Nerv Syst Agents Med Chem2021; 21: 195–204.
24.
LachanceVWangQSweetE, et al.Autophagy protein NRBF2 has reduced expression in Alzheimer's brains and modulates memory and amyloid-beta homeostasis in mice. Mol Neurodegener2019; 14: 43.
25.
TakeshitaYHashimotoYNawaM, et al.SH3-binding Protein 5 mediates the neuroprotective effect of the secreted bioactive peptide humanin by inhibiting c-jun NH2-terminal kinase. J Biol Chem2013; 288: 24691–24704.
26.
HashimotoYKusakariSNawaM, et al.Restoration of the reduced CLSP activity alleviates memory impairment in Alzheimer disease. Transl Psychiatry2021; 11: 44.
LiQSDe MuynckL. Differentially expressed genes in Alzheimer's disease highlighting the roles of microglia genes including OLR1 and astrocyte gene CDK2AP1. Brain Behav Immun Health2021; 13: 100227.
29.
SuLChenSZhengC, et al.Meta-analysis of gene expression and identification of biological regulatory mechanisms in Alzheimer's disease. Front Neurosci2019; 13: 633.
30.
StrefelerAJanMQuadroniM, et al.Molecular insights into sex-specific metabolic alterations in Alzheimer's mouse brain using multi-omics approach. Alzheimers Res Ther2023; 15: 8.
31.
FernandezRFPereyraASDiazV, et al.Acyl-CoA synthetase 6 is required for brain docosahexaenoic acid retention and neuroprotection during aging. JCI Insight2021; 6: e144351.
32.
Akila Parvathy DharshiniSTaguchiYHMichael GromihaM. Exploring the selective vulnerability in Alzheimer disease using tissue specific variant analysis. Genomics2019; 111: 936–949.
33.
LianPCaiXWangC, et al.Identification of metabolism-related subtypes and feature genes in Alzheimer's disease. J Transl Med2023; 21: 628.
34.
KambohMIBarmadaMMDemirciFY, et al.Genome-wide association analysis of age-at-onset in Alzheimer's disease. Mol Psychiatry2012; 17: 1340–1346.
35.
ZhuMXiaoBXueT, et al.Cdc42GAP deficiency contributes to the Alzheimer's disease phenotype. Brain2023; 146: 4350–4365.
36.
SilvaISilvaJFerreiraR, et al.Glymphatic system, AQP4, and their implications in Alzheimer's disease. Neurol Res Pract2021; 3: 5.
37.
ArighiAArcaroMFumagalliGG, et al.Aquaporin-4 cerebrospinal fluid levels are higher in neurodegenerative dementia: looking at glymphatic system dysregulation. Alzheimers Res Ther2022; 14: 135.
38.
ZeppenfeldDMSimonMHaswellJD, et al.Association of perivascular localization of aquaporin-4 with cognition and Alzheimer disease in aging brains. JAMA Neurol2017; 74: 91–99.
39.
SongHYangJYuW. Promoter hypomethylation of TGFBR3 as a risk factor of Alzheimer's disease: an integrated epigenomic-transcriptomic analysis. Front Cell Dev Biol2021; 9: 825729.
40.
KuramotoKNegishiMKatohH. Regulation of dendrite growth by the Cdc42 activator Zizimin1/Dock9 in hippocampal neurons. J Neurosci Res2009; 87: 1794–1805.
41.
KuznetsovaILPonomarevaNVAlemastsevaEA, et al.The interactive effect of genetic and epigenetic variations in FKBP5 and ApoE genes on anxiety and brain EEG parameters. Genes (Basel)2022; 13: 164.
42.
GebruNTHillSEBlairLJ. Development of FKBP5 ASOs to mitigate tau pathology. Alzheimers Dement2023; 19: e082780.
43.
IqbalZVandeweyerGvan der VoetM, et al.Homozygous and heterozygous disruptions of ANK3: at the crossroads of neurodevelopmental and psychiatric disorders. Hum Mol Genet2013; 22: 1960–1970.
44.
PelucchiSStringhiRMarcelloE. Dendritic spines in Alzheimer's disease: how the actin cytoskeleton contributes to synaptic failure. Int J Mol Sci2020; 21: 908.
45.
GoldsteinBSpethRCTrivediM. Renin-angiotensin system gene expression and neurodegenerative diseases. J Renin Angiotensin Aldosterone Syst2016; 17: 1470320316666750.
46.
GaviniCKWhiteCRMansuy-AubertV, et al.Loss of C2 domain protein (C2CD5) alters hypothalamic mitochondrial trafficking, structure, and function. Neuroendocrinology2022; 112: 324–337.
47.
ZhangQZhangJYeJ, et al.Nuclear speckle specific hnRNP D-like prevents age- and AD-related cognitive decline by modulating RNA splicing. Mol Neurodegener2021; 16: 66.
48.
BamptonAGittingsLMFrattaP, et al.The role of hnRNPs in frontotemporal dementia and amyotrophic lateral sclerosis. Acta Neuropathol2020; 140: 599–623.
49.
KimHRLeeTChoiJK, et al.Polymorphism in the MAGI2 gene modifies the effect of amyloid beta on neurodegeneration. Alzheimer Dis Assoc Disord2021; 35: 114–120.
50.
ZhangJWangR. Deregulated lncRNA MAGI2-AS3 in Alzheimer's disease attenuates amyloid-beta induced neurotoxicity and neuroinflammation by sponging miR-374b-5p. Exp Gerontol2021; 144: 111180.
51.
SoaresACFerreiraAMarienJ, et al.PIKfyve activity is required for lysosomal trafficking of tau aggregates and tau seeding. J Biol Chem2021; 296: 100636.
52.
BalklavaZNiehageCCurrinnH, et al.The amyloid precursor protein controls PIKfyve function. PLoS One2015; 10: e0130485.
53.
WagnerMSkorobogatkoYPode-ShakkedB, et al.Bi-allelic variants in RALGAPA1 cause profound neurodevelopmental disability, muscular hypotonia, infantile spasms, and feeding abnormalities. Am J Hum Genet2020; 106: 246–255.
54.
BagariaJBagyinszkyEAnSSA. Genetics of autosomal recessive spastic ataxia of charlevoix-saguenay (ARSACS) and role of sacsin in neurodegeneration. Int J Mol Sci2022; 23: 552.
55.
DesikanRSSchorkAJWangY, et al.Genetic overlap between Alzheimer's disease and Parkinson's disease at the MAPT locus. Mol Psychiatry2015; 20: 1588–1595.
56.
ZhangQMaCGearingM, et al.Integrated proteomics and network analysis identifies protein hubs and network alterations in Alzheimer's disease. Acta Neuropathol Commun2018; 6: 19.
57.
SilvaPNGigekCOLealMF, et al.Promoter methylation analysis of SIRT3, SMARCA5, HTERT and CDH1 genes in aging and Alzheimer's disease. J Alzheimers Dis2008; 13: 173–176.
58.
BalastikMFerragutiFPires-da SilvaA, et al.Deficiency in ubiquitin ligase TRIM2 causes accumulation of neurofilament light chain and neurodegeneration. Proc Natl Acad Sci U S A2008; 105: 12016–12021.
59.
GratuzeMLeynsCEGHoltzmanDM. New insights into the role of TREM2 in Alzheimer's disease. Mol Neurodegener2018; 13: 66.
60.
DubalDB. Sex difference in Alzheimer's disease: an updated, balanced and emerging perspective on differing vulnerabilities. Handb Clin Neurol2020; 175: 261–273.
61.
ArnoldSEHymanBTVan HoesenGW. Neuropathologic changes of the temporal pole in Alzheimer's disease and pick's disease. Arch Neurol1994; 51: 145–150.
62.
de JongLWvan der HieleKVeerIM, et al.Strongly reduced volumes of putamen and thalamus in Alzheimer's disease: an MRI study. Brain2008; 131: 3277–3285.
63.
BrewerAABartonB. Visual cortex in aging and Alzheimer's disease: changes in visual field maps and population receptive fields. Front Psychol2014; 5: 74.
64.
LinFRenPLoRY, et al.Insula and inferior frontal gyrus’ activities protect memory performance against Alzheimer's disease pathology in old age. J Alzheimers Dis2017; 55: 669–678.
65.
PerssonKBohbotVDBogdanovicN, et al.Finding of increased caudate nucleus in patients with Alzheimer's disease. Acta Neurol Scand2018; 137: 224–232.
66.
JungFKazemifarSBarthaR, et al.Semiautomated assessment of the anterior cingulate cortex in Alzheimer's disease. J Neuroimaging2019; 29: 376–382.
67.
PrawiroharjoPYamashitaKIYamashitaK, et al.Disconnection of the right superior parietal lobule from the precuneus is associated with memory impairment in oldest-old Alzheimer's disease patients. Heliyon2020; 6: e04516.
68.
MigliaccioRCacciamaniF. The temporal lobe in typical and atypical Alzheimer disease. Handb Clin Neurol2022; 187: 449–466.
69.
WoodOWGWalbyJYeungJH, et al.Alzheimer's disease-associated region-specific decrease of vesicular glutamate transporter immunoreactivity inthe medial temporal lobe and superior temporal gyrus. Neuroscience2024; 546: 75–87.
70.
LengKLiEEserR, et al.Molecular characterization of selectively vulnerable neurons in Alzheimer's disease. Nat Neurosci2021; 24: 276–287.
ScheffSWPriceDASchmittFA, et al.Synaptic loss in the inferior temporal gyrus in mild cognitive impairment and Alzheimer's disease. J Alzheimers Dis2011; 24: 547–557.
73.
JiangYAnX. Speech differences between aged women with and without early Alzheimer's disease: linguistic indicators of cognitive decline. Acta Psychol (Amst)2025; 256: 105008.
74.
RipichDNPetrillSAWhitehousePJ, et al.Gender differences in language of AD patients: a longitudinal study. Neurology1995; 45: 299–302.
75.
KoenigsMBarbeyAKPostleBR, et al.Superior parietal cortex is critical for the manipulation of information in working memory. J Neurosci2009; 29: 14980–14986.
76.
ChoudhuryNChenLAl-HarthiL, et al.Hyperactivity of medial prefrontal cortex pyramidal neurons occurs in a mouse model of early-stage Alzheimer's disease without beta-amyloid accumulation. Front Pharmacol2023; 14: 1194869.
77.
PalmqvistSSchollMStrandbergO, et al.Earliest accumulation of beta-amyloid occurs within the default-mode network and concurrently affects brain connectivity. Nat Commun2017; 8: 1214.
78.
MailletDRajahMN. Association between prefrontal activity and volume change in prefrontal and medial temporal lobes in aging and dementia: a review. Ageing Res Rev2013; 12: 479–489.
79.
SampathDSathyanesanMNewtonSS. Cognitive dysfunction in major depression and Alzheimer's disease is associated with hippocampal-prefrontal cortex dysconnectivity. Neuropsychiatr Dis Treat2017; 13: 1509–1519.
80.
CornellJSalinasSHuangHY, et al.Microglia regulation of synaptic plasticity and learning and memory. Neural Regen Res2022; 17: 705–716.
81.
TanYLYuanYTianL. Microglial regional heterogeneity and its role in the brain. Mol Psychiatry2020; 25: 351–367.
82.
St-PierreMKVanderZwaagJLoewenS, et al.All roads lead to heterogeneity: the complex involvement of astrocytes and microglia in the pathogenesis of Alzheimer's disease. Front Cell Neurosci2022; 16: 932572.
83.
TakataKGinhouxFShimohamaS. Roles of microglia in Alzheimer's disease and impact of new findings on microglial heterogeneity as a target for therapeutic intervention. Biochem Pharmacol2021; 192: 114754.
84.
CasalettoKBNicholsEAslanyanV, et al.Sex-specific effects of microglial activation on Alzheimer's disease proteinopathy in older adults. Brain2022; 145: 3536–3545.
85.
MangoldCAWronowskiBDuM, et al.Sexually divergent induction of microglial-associated neuroinflammation with hippocampal aging. J Neuroinflammation2017; 14: 141.
86.
WehrspaunCCHaertyWPontingCP. Microglia recapitulate a hematopoietic master regulator network in the aging human frontal cortex. Neurobiol Aging2015; 36: 2443 e2449–2443 e2420.
87.
QuekHCuni-LopezCStewartR, et al.ALS monocyte-derived microglia-like cells reveal cytoplasmic TDP-43 accumulation, DNA damage, and cell-specific impairment of phagocytosis associated with disease progression. J Neuroinflammation2022; 19: 58.
88.
PreisslerJGroscheALedeV, et al.Altered microglial phagocytosis in GPR34-deficient mice. Glia2015; 63: 206–215.
89.
ZhouYHuangZLinB, et al.Demyelination-derived lysophosphatidylserine promotes microglial dysfunction and neuropathology in a mouse model of Alzheimer’s disease. Cell Mol Immunol2025; 22: 134–149.
90.
Guillot-SestierMVAraizARMelaV, et al.Microglial metabolism is a pivotal factor in sexual dimorphism in Alzheimer's disease. Commun Biol2021; 4: 711.
91.
LynchMA. Exploring sex-related differences in microglia may be a game-changer in precision medicine. Front Aging Neurosci2022; 14: 868448.
92.
GuneykayaDIvanovAHernandezDP, et al.Transcriptional and translational differences of microglia from male and female brains. Cell Rep2018; 24: 2773–2783.e6.
93.
JaroudiWGaramiJGarridoS, et al.Factors underlying cognitive decline in old age and Alzheimer's disease: the role of the hippocampus. Rev Neurosci2017; 28: 705–714.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
